This study aims to identify the incidence and risk factors of periprosthetic infections following endoprosthetic reconstruction of femoral metastatic bone disease (MBD).
In this population with MBD, the marked impact of infection on the patient's systemic treatment highlights the importance of understanding both the incidence and associated risk factors.
